Disc Medicine Inc

For the period ended Dec 31, 2023. Filed Mar 21, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 21, 2024

IRON$81.26+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,	December 31,
	2023	2022
Assets ·
Current assets: ·
Cash and cash equivalents	$360,382	$194,611
Prepaid expenses and other current assets	5,280	3,880
Total current assets	365,662	198,491
Property and equipment, net	170	168
Right-of-use assets, operating leases	1,930	1,430
Other assets	234	116
Total assets	$367,996	$200,205
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$12,629	$16,162
Accrued expenses	8,145	6,109
Operating lease liabilities, current	665	307
Total current liabilities	21,439	22,578
Operating lease liabilities, non-current	1,436	1,027
Total liabilities	22,875	23,605
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.0001 par value; 100,000,000 shares authorized as of December 31, 2023 and 2022; 24,360,233 and 17,405,231 shares issued as of December 31, 2023 and 2022, respectively; and 24,360,233 and 17,403,315 shares outstanding as of December 31, 2023 and 2022, respectively	2	2
Additional paid-in capital	533,764	288,814
Accumulated deficit	(188,645)	(112,216)
Total stockholders’ equity	345,121	176,600
Total liabilities and stockholders’ equity	$367,996	$200,205

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.